During the past decade, Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z. conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 22 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 17 clinical trials were completed. i.e. 141.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z." #1 sponsor was "Pfizer" with 10 trials, followed by "Anika Therapeutics, Inc." with 6 trials sponsored, "Shire" with 5 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z." #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z." are "Ulcerative Colitis" (6 trials), "Psoriasis" (4 trials), "Atopic Dermatitis" (3 trials), "Crohn's Disease" (3 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z." in a lesser frequency.

Most popular intervention types in "Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z." are "Drug" (34 trials), "Biological" (8 trials), "Device" (6 trials), "Other" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Cingal" (3 trials), "Monovisc" (3 trials), "BMS-986165" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z." are 41 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z.". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z., 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".

Krajska zdravotni, a.s., Masarykova nemocnice v Usti nad Labem o.z. has several departments that took part in Clinical trials: "Krajska zdravotni, a. s. - Nemocnice Teplice, o. z.; Neurologicke oddeleni" - 4 trials, "Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem, o.z. Oddeleni gastroenterolgie" - 2 trials, "Psychiatricka ordinace" - 2 trials